Which hedge funds own CNTB? CONNECT BIOPHARMA HLDGS LTD, Q2 2026 13F holders
17 tracked hedge funds disclosed a position in CNTB (CONNECT BIOPHARMA HLDGS LTD) in their Q2 2026 13F filings, worth $25.8m in total. The largest holder by portfolio weight is Ikarian Capital, LLC at 1.8% of its book. 2 opened a new position this quarter: Silverarc Capital Management, LLC, Y-Intercept (Hong Kong) Ltd. 4 exited: Propel Bio Management, LLC, Fifth Lane Capital, LP, Citadel Advisors LLC.
- 17
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 2
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 4
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $1.3m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $923k
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $25.8m
- Combined value Sum of the holders' reported positions in the security.
- 1.4%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
| Ikarian Capital, LLC Hedge fund | 1.8% | −16% | reduced |
| BML Capital Management, LLC Hedge fund | 0.8% | +40% | added |
| Stonepine Capital Management, LLC Hedge fund | 0.7% | +18% | added |
| 683 Capital Management, LLC Hedge fund | 0.3% | +43% | added |
| Diadema Partners LP Hedge fund | 0.2% | −1.8% | reduced |
| Silverarc Capital Management, LLC Hedge fund | 0.1% | – | new |
| ADAR1 Capital Management, LLC Hedge fund | 0.08% | −5.7% | reduced |
| Boothbay Fund Management, LLC Hedge fund | 0.04% | −21% | reduced |
| Persistent Asset Partners Ltd Hedge fund | 0.04% | −1.7% | reduced |
| Perceptive Advisors LLC Hedge fund | 0.03% | 0.0% | held |
| Burkehill Global Management, LP Hedge fund | 0.01% | 0.0% | held |
| FNY Investment Advisers, LLC Hedge fund | 0.0% | 0.0% | held |
| Y-Intercept (Hong Kong) Ltd Hedge fund | 0.0% | – | new |
| Marshall Wace, LLP Hedge fund | 0.0% | +408% | added |
| Two Sigma Investments, LP Hedge fund | 0.0% | +320% | added |
| Renaissance Technologies LLC Hedge fund | 0.0% | −28% | reduced |
| Millennium Management LLC Hedge fund | 0.0% | −91% | reduced |
Exited since the previous filing
| Propel Bio Management, LLC | 0.3% | $554k |
| Fifth Lane Capital, LP | 0.1% | $118k |
| Citadel Advisors LLC | 0.0% | $199k |
| Point72 Asset Management, L.P. | 0.0% | $51.8k |
Ownership over time
Who discovered CNTB first? Beta
The run: Q1 2025 → Q4 2025, +413%
| BML Capital Management, LLC | Q2 2025 | 0.9% | +2.2 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.